The mammalian low-density lipoprotein receptor family

Annual Review of Nutrition

Volumn 19, Issue , 1999, Pages 141-172

  Hussain, M Mahmood ^a   Strickland, Dudley K ^b   Bakillah, Ahmed ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b American Red Cross ^*  (United States)

Author keywords

Endocytosis; Ligands; Lipoprotein catabolism; Proteinase catabolism

Indexed keywords

LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

CORONARY ARTERY DISEASE; ENDOCYTOSIS; HYPERCHOLESTEROLEMIA; LIGAND BINDING; LIPOPROTEIN METABOLISM; LYSOSOME; MAMMAL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; DIETARY FATS; GENE EXPRESSION REGULATION; GENETIC DISEASES, INBORN; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; RECEPTORS, LDL;

ANIMALIA; GALLUS GALLUS; MAMMALIA;

EID: 0032802253     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.19.1.141     Document Type: Review

References (208)

1. 1. Argraves KM, Battey FD, Maccalman CD, McCrae KR, Gåfvels ME, et al. 1995. The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes. J. Biol. Chem. 270: 26550-57
2. 2. Argraves KM, Kozarsky KF, Fallon JT, Harpel PC, Strickland DK. 1997. The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor. J. Clin. Invest. 100:2170-81
3. 2-macroglobulin receptor: identification of a 420-kDa cell surface glycoprotein specific for the activated conformation of alpha2-macroglobulin. J. Cell Biol. 110:1041-48
4. 4. Battey FD, Gåfvels ME, Fitzgerald DJ, Argraves WS, Chappell DA, et al. 1994. The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor. J. Biol. Chem. 269:23268-73
5. 5. Beisiegel U, Weber W, Bengtsson-Olivecrona G. 1991. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc. Natl. Acad. Sci. USA 88: 8342-46
6. 6. Beisiegel U, Weber W, Ihrke G, Herz J, Stanley KK. 1989. The LDL-rcceptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature 341:162-64
7. 7. Blacker D, Wilcox MA, Laird NM, Rodes L, Horvath SM, et al. 1998. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat. Genet. 19:357-60
8. 8. Borén J, Lee I, Zhu WM, Arnold KS, Taylor S, Innerarity TL. 1998. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100. J. Clin. Invest. 101:1084-93
9. 9. Brandes C, Novak S, Stockinger W, Herz J, Schneider WJ, Nimpf J. 1997. Avian and murine LR8B and human apolipoprotein E receptor 2: differentially spliced products from corresponding genes. Genomics 42:185-91
10. 10. Brown MS, Goldstein JL. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47
11. 11. Brown MS, Goldstein JL. 1997. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89:331-40
12. 12. Brown MS, Herz J, Kowal RC, Goldstein JL. 1991. The low-density lipoprotein receptor-related protein: double agent or decoy? Curr. Opin. Lipidol. 2:65-72
13. 13. Brown SD, Twells RCJ, Hey PJ, Cox RD, Levy ER, et al. 1998. Isolation and characterization of LRP6, a novel member of the low density lipoprotein receptor gene family. Biochem. Biophys. Res. Commun. 248:879-88
14. 14. Bu G. 1998. Receptor-associated protein: a specialized chaperone and antagonist for members of the LDL receptor gene family. Curr. Opin. Lipidol. 9:149-55
15. 15. Bu G, Geuze HJ, Strous GJ, Schwartz AL. 1995. 39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein. EMBO J. 14:2269-80
16. 16. Bu G, Maksymovitch A, Schwartz AL. 1993. Receptor-mediated endocytosis of tissue-type plasminogen activator by low density lipoprotein receptor-related protein on human hepatoma HepG2 cells. J. Biol. Chem. 268:13002-9
17. 17. Bu G, Rennke S. 1996. Receptor-associated protein is a folding chaperone for low density lipoprotein receptor-related protein. J. Biol. Chem. 271:22218-24
18. 18. Bu G, Sun YL, Schwartz AL, Holtzman DM. 1998. Nerve growth factor induces rapid increases in functional cell surface low density lipoprotein receptor-related protein. J. Biol. Chem. 273:13359-65
19. 2-macroglobulin receptor is a hepatic receptor for tissue-type plasminogen activator. Proc. Natl. Acad. Sci. USA 89:7427-31
20. 20. Bujo H, Yamamoto T, Hayashi K, Hermann M, Nimpf J, Schneider WJ. 1995. Mutant oocytic low density lipoprotein receptor gene family member causes atherosclerosis and female sterility. Proc. Natl. Acad. Sci. USA 92:9905-9
21. 21. Cavallaro U, Nykjaer A, Nielsen M, Soria MR. 1995. Alpha 2-macroglobulin receptor mediates binding and cytotoxicity of plant ribosome-inactivating proteins. Eur. J. Biochem. 232:165-71
22. 2-macroglobulin receptor binds and mediates catabolism of bovine milk lipoprotein lipase. J. Biol. Chem. 267:25764-67
23. 23. Chatterton JE, Phillips ML, Curtiss LK, Milne R, Fruchart JC, Schumaker VN. 1995. Immunoelectron microscopy of low density lipoproteins yields a ribbon and bow model for the conformation of apolipoprotein B on the lipoprotein surface. J. Lipid Res. 36:2027-37
24. 24. Christensen EI, Birn H, Verroust P, Moestrup SK. 1998. Membrane receptors for endocytosis in the renal proximal tubule. Int. Rev. Cytol. 180:237-84
25. 2-Macroglobulin, complement, biologic defense: antigens, growth factors, microbial proteases, and receptor ligation. Lab. Invest. 71:792-812
26. 26. Conese M, Cavallaro U, Sidenius N, Olson D, Soria MR, Blasi F. 1995. PMA-induced down-regulation of the receptor for alpha 2-macroglobulin in human U937 cells. FEBS Lett. 358:73-78
27. 2-macroglobulin receptor. J. Biol. Chem. 269:17886-92
28. 28. Cooper AD. 1997. Hepatic uptake of chylomicron remnants. J. Lipid Res. 38: 2173-92
29. 29. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, et al. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science 261:921-23
30. 30. Crowther RA. 1995. Steps towards a mouse model of Alzheimer's disease. BioEssays 17:593-95
31. 31. Cui S, Verroust PJ, Moestrup SK, Christensen El. 1996. Megalin/gp330 mediates uptake of albumin in renal proximal tubule. Am. J. Physiol. 271(2):F900-7
32. 32. Czekay RP, Orlando RA, Woodward L, Adamson ED, Farquhar MG. 1995. The expression of megalin (gp330) end LRP diverges during F9 cell differentiation. J. Cell Sci. 108:1433-41
33. 33. Daly NL, Scanlon MJ, Djordjevic JT, Kroon PA, Smith R. 1995. Three-dimensional structure of a cysteine-rich repeat from the low-density lipoprotein receptor. Proc. Natl. Acad. Sci. USA 92:6334-38
34. 34. Descamps O, Bilheimer D, Herz J. 1993. Insulin stimulates receptor-mediated uptake of apoE-enriched lipoproteins and activated alpha 2-macroglobulin in adipocytes. J. Biol. Chem. 268:974-81
35. 2-Macroglobulin attenuates beta-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons. J. Neurochem. 70:1182-88
36. 36. Ellgaard L, Holtet TL, Nielsen PR, Etzerodt M, Gliemann J, Thogersen HC. 1997. Dissection of the domain architecture of the alpha2 macroglobulin-receptor-associated protein. Eur. J. Biochem. 244:544-51; Erratum. 1997. Eur. J. Biochem. 248(34):947
37. 36. Ellgaard L, Holtet TL, Nielsen PR, Etzerodt M, Gliemann J, Thogersen HC. 1997. Dissection of the domain architecture of the alpha2 macroglobulin-receptor-associated protein. Eur. J. Biochem. 244:544-51; Erratum. 1997. Eur. J. Biochem. 248(34):947
38. 37. Esser V, Limbird LE, Brown MS, Goldstein JL, Russell DW. 1988. Mutational analysis of the ligand binding domain of the low density lipoprotein receptor. J. Biol. Chem. 263:13282-90
39. 38. Farquhar MG, Kerjaschki D, Lundstrom M, Orlando RA. 1994. gp330 and RAP: the Heymann nephritis antigenic complex. Ann. NY Acad. Sci. 737:96-113
40. 39. Farquhar MG, Saito A, Kerjaschki D, Orlando RA. 1995. The Heymann nephritis antigenic complex: megalin (gp330) and RAP. J. Am. Soc. Nephrol. 6:35-47
41. 40. Fass D, Blacklow S, Kim PS, Berger JM. 1997. Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module. Nature 388:691-93
42. 41. Frykman PK, Brown MS, Yamamoto T, Goldstein JL, Herz J. 1995. Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA 92:8453-57
43. 42. Gaeta BA, Borthwick I, Stanley KK. 1994. The 5′-flanking region of the alpha 2MR/LRP gene contains an enhancer-like cluster of Sp1 binding sites. Biochim. Biophys. Acta 1219:307-13
44. 2-macroglobulin receptor/low density lipoprotein receptor-related protein: differentiation and cAMP modulate protein and mRNA levels. J. Biol. Chem. 267: 21230-34
45. 44. Gettins P, Patston PA, Schapira M. 1992. Structure and mechanism of action of serpins. Hematol. Oncol. Clin. N. Am. 6:1393-408
46. 45. Goldstein JL, Brown MS. 1990. Regulation of the mevalonate pathway. Nature 343:425-30
47. 46. Goldstein JL, Hobbs HH, Brown MS. 1995. Familial hypercholesterolemia. In The Metabolic and Molecular Bases of Inherited Disorders, ed. CR Scriver, et al, pp. 1981-2030. New York: McGraw-Hill
48. 47. Hammad SM, Ranganathan S, Loukinova E, Twal WO, Argraves WS. 1997. Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/ megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide. J. Biol. Chem. 272:18644-49
49. 48. Deleted in proof
50. 49. Havel RJ. 1994. Postprandial hyperlipidemia and remnant lipoproteins. Curr. Opin. Lipidol. 5:102-9
51. 50. Heegaard CW, Simonsen ACW, Oka K, Kjoller L, Christensen A, et al. 1995. Very low density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen activator-type-1 plasminogen activator inhibitor complex. J. Biol. Chem. 270:20855-61
52. 51. Herz J. 1993. The LDL-receptor-related protein-portrait of a multifunctional receptor. Curr. Opin. Lipidol. 4:107-13
53. 52. Herz J, Clouthier DE, Hammer RE. 1992. LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell 71:411-21
54. 2-macroglobulin receptor. J. Biol. Chem. 266:21232-38
55. 54. Herz J, Hamann U, Rogne S, Myklebost O, Gausepohl H, Stanley KK. 1988. Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J. 7:4119-27
56. 55. Herz J, Kowal RC, Goldstein JL, Brown MS. 1990. Proteolytic processing of the 600 kd low density lipoprotein receptor-related protein (LRP) occurs in a trans-Golgi compartment. EMBO J. 9:1769-76
57. 56. Hey PJ, Twells RCJ, Philips MS, Nakagawa Y, Brown SD, et al. 1998. Cloning of a novel member of the low-density lipoprotein receptor family. Gene 216: 103-11
58. 57. Hiesberger T, Huttler S, Rohlmann A, Schneider WJ, Sandhoff K, Herz J. 1998. Cellular uptake of saposin (SAP) precursor and lysosomal delivery by the low density lipoprotein receptor-related protein (LRP). EMBO J. 17:4617-25
59. 58. Ho L, Fukuchi KI, Younkin SG. 1996. The alternatively spliced Kunitz protease inhibitor domain alters amyloid beta protein precursor processing and amyloid beta protein production in cultured cells. J. Biol. Chem. 271:30929-34
60. 59. Hobbs HH, Russell DW, Brown MS, Goldstein JL. 1990. The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. Annu. Rev. Genet. 24:133-70
61. 60. Hollenbach E, Ackermann S, Hyman BT, Rebeck GW. 1998. Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease. Neurology 50:1905-7
62. 61. Horn IR, Moestrup SK, Van den Berg BMM, Pannekoek H, Nielsen MS, Van Zonneveld A-J. 1995. Analysis of the binding of pro-urokinase and urokinase-plasminogen activator inhibitor-1 complex to the low density lipoprotein receptor-related protein using a Fab fragment selected from a phage-displayed Fab library. J. Biol. Chem. 270:11770-75
63. 2-Macroglobulin associates with beta-amyloid peptide and prevents fibril formation. Proc. Natl. Acad. Sci. USA 95:3275-80
64. 63. Hussain MM, Goldberg IJ, Weisgraber KH, Mahley RW, Innerarity TL. 1997. Uptake of chylomicrons by the liver, but not by the bone marrow, is modulated by lipoprotein lipase activity. Arterioscler. Thromb. Vasc. Biol. 17:1407-13
65. 2-macroglobulin receptor. Biochemistry 34:16074-81
66. 65. Hussain MM, Kancha RK, Zhou Z, Luchoomun J, Zu H, Bakillah A. 1996. Chylomicron assembly and catabolism: role of apolipoproteins and receptors. Biochim. Biophys. Acta 1300:151-70
67. 66. Hussain MM, Mahley RW, Boyles JK, Fainaru M, Brecht WJ, Lindquist PA. 1989. Chylomicron-chylomicron remnant clearance by liver and bone marrow in rabbits: factors that modify tissue-specific uptake. J. Biol. Chem. 264: 9571-82
68. 67. Hussain MM, Mahley RW, Boyles JK, Lindquist PA, Brecht WJ, Innerarity TL. 1989. Chylomicron metabolism: chylomicron uptake by bone marrow in different animal species. J. Biol. Chem. 264:17931-38
69. 2-macroglobulin receptor. J. Biol. Chem. 266:13936-40
70. 69. Hussaini IM, LaMarre J, Lysiak JJ, Karns LR, VandenBerg SR, Gonias SL. 1996. Transcriptional regulation of LDL receptor-related protein by IFN-gamma and the antagonistic activity of TGF-beta 1 in the RAW 264. 7 macrophage-like cell line. J. Leukocyte Biol. 59:733-39
71. 2-macroglobulin receptor expression in murine bone marrow macrophages. J. Biol. Chem. 265:19441-46
72. 71. Ishibashi T, Yokoyama K, Shindo J, Hamazaki Y, Endo Y, et al. 1994. Potent cholesterol-lowering effect by human granulocyte-macrophage colony-stimulating factor in rabbits - possible implications of enhancement of macrophage functions and an increase in mRNA for VLDL receptor. Arterioscler. Thromb. 14:1534-41
73. 72. Ishii H, Kim DH, Fujita T, Endo Y, Saeki S, Yamamoto TT. 1998. cDNA cloning of a new low-density lipoprotein receptor-related protein and mapping of its gene (LRP3) to chromosome bands 19q12-q13. 2. Genomics 51:132-35
74. 73. Jacobsen L, Madsen P, Moestrup SK, Lund AH, Tommerup N, et al. 1996. Molecular characterization of a novel human hybrid-type receptor that binds the alpha2-macroglobulin receptor-associated protein. J. Biol. Chem. 271: 31379-83
75. 74. Jingami H, Yamamoto T. 1995. The VLDL receptor: wayward brother of the LDL receptor. Curr. Opin. Lipidol. 6:104-8
76. 75. Jokinen EV, Landschulz KT, Wyne KL, Ho YK, Frykman PK, Hobbs HH. 1994. Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle. J. Biol. Chem. 269: 26411-18
77. 76. Kamboh MI, Ferrell RE, DeKosky ST. 1998. Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene. Neurosci. Lett. 244:65-68
78. 77. Kanalas JJ, Makker SP. 1991. Identification of the rat Heymann nephritis autoantigen (GP330) us a receptor site for plasminogen. J. Biol. Chem. 266:10825-29
79. 78. Kancha RK, Hussain MM. 1996. Up-regulation of the low density lipoprotein receptor-related protein by dexamethasone in HepG2 cells. Biochim. Biophys. Acta 1301:213-20
80. 2-macroglobulin. Biochim. Biophys. Acta 1355:231-40
81. 2-macroglobulin receptor in invasive cell clones derived from human prostate and breast tumor cells. Oncol. Res. 6:365-72
82. 81. Kang DE, Saitoh T, Chen X, Xia Y, Masliah E, et al. 1997. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology 49:56-61
83. 82. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, et al. 1987. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733-36
84. 2-macroglobulin receptor low-density-lipoprotein-receptor-related protein. Eur. J. Biochem. 248:270-81
85. 84. Kerjaschki D, Neale TJ. 1996. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis). J. Am. Soc. Nephrol. 7:2518-26
86. 85. Kibbey RG, Rizo J, Gierasch LM, Anderson RGW. 1998. The LDL receptor clustering motif interacts with the clathrin terminal domain in a reverse turn conformation. J Cell Biol. 142:59-67
87. 86. Kim DH, Iijima H, Goto K, Sakai J, Ishii H, et al. 1996. Human apolipoprotein E receptor 2 - a novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J. Biol. Chem. 271:8373-80
88. 87. Kobayashi K, Oka K, Forte T, Ishida B, Teng BB, et al. 1996. Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor. J. Biol. Chem. 271:6852-60
89. 2-macroglobulin receptor and glycoprotein 330. J. Biol. Chem. 267:21162-66
90. 89. Kounnas MZ, Chappell DA, Strickland DK, Argraves WS. 1993. Glycoprotein 330, a member of the low density lipoprotein receptor family, binds lipoprotein lipase in vitro. J. Biol. Chem. 268:14176-81
91. 90. Kounnas MZ, Chappell DA, Wong H, Argraves WS, Strickland DK. 1995. The cellular internalization and degradation of hepatic lipase is mediated by low density lipoprotein receptor-related protein and requires cell surface proteoglycans. J. Biol. Chem. 270:9307-12
92. 91. Kounnas MZ, Church FC, Argraves WS, Strickland DK. 1996. Cellular internalization and degradation of antithrombin III-thrombin, heparin cofactor II-thrombin, and alpha(1)-antitrypsin-trypsin complexes is mediated by the low density lipoprotein receptor-related protein. J. Biol. Chem. 271:6523-29
93. 2-macroglobulin receptor mediates cellular uptake of pro-urokinase. J. Biol. Chem. 268:21862-67
94. 93. Kounnas MZ, Loukinova EB, Stefansson S, Harmony JAK, Brewer BH, et al. 1995. Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein I/clusterin. J. Biol. Chem. 270:13070-75
95. 94. Kounnas MZ, Moir RD, Rebeck GW, Bush AI, Argraves WS, et al. 1995. LDL receptor-related protein, a multi-functional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell 82:331-40
96. 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. J. Biol. Chem. 267:12420-23
97. 96. Kowal RC, Herz J, Goldstein JL, Esser V, Brown MS. 1989. Low density receptor-related protein mediates uptake of cholesteryl esters derived from apolipoprotein E-enriched lipoproteins. Proc. Natl. Acad. Sci. USA 86:5810-14
98. 97. Kozarsky KF, Jooss K, Donahee M, Strauss JF, Wilson JM. 1996. Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer or the VLDL receptor gene. Nat. Genet. 13:54-62
99. 98. Krapp A, Ahle S, Kersting S, Hua Y, Kneser K, et al. 1996. Hepatic lipase mediates the uptake of chylomicrons and beta-VLDL into cells via the LDL receptor-related protein (LRP). J. Lipid Res. 37:926-36
100. 99. Krieger M, Herz J. 1994. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63:601-37
101. 2-macroglobulin receptor. FEBS Lett. 276:151-55
102. 101. Kutt H, Herz J, Stanley KK. 1989. Structure of the low-density lipoprotein receptor-related protein (LRP) promoter. Biochim. Biophys. Acta 1009: 229-36
103. 2-macroglobulin receptor/low density lipoprotein receptor-related protein by lipopolysaccharide and interferon-γ. J. Clin. Invest. 91:1219-24
104. 103. Lambert JC, Wavrant-De Vrieze F, Amouyel P, Chartier-Harlin MC. 1998. Association at LRP gene locus with sporadic late-onset Alzheimer's disease. Lancet 351:1787-88
105. 2-macroglobulin receptor in human fibroblasts, absent in tumor-derived cell lines. J. Biol. Chem. 254:5155-60
106. 105. Liang K, Vaziri ND. 1997. Acquired VLDL receptor deficiency in experimental nephrosis. Kidney Int. 51:1761-65
107. 106. Liu W, Yu WR, Carling T, Juhlin C, Rastad J, et al. 1998. Regulation of gp330/ megalin expression by vitamins A and D. Eur. J. Clin. Invest. 28:100-7
108. 107. Lorent K, Overbergh L, Delabie J, Vanleuven F, Vandenberghe H. 1994. Distribution of mRNA coding for alpha-2-macroglobulin, the murinoglobulins, the alpha-2-macroglobulin receptor and the alpha-2-macroglobulin receptor associated protein during mouse embryogenesis and in adult tissues. Differentiation 55:213-23
109. 108. Mahley RW. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622-30
110. 109. Mahley RW, Hussain MM. 1991. Chylomicron and chylomicron remnant catabolism. Curr. Opin. Lipidol. 2:170-76
111. 110. Mahley RW, Weisgraber KH, Hussain MM, Greenman B, Fisher M, et al. 1989. Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits. J. Clin. Invest. 83:2125-30
112. 110a. Mahley RW, Ji ZS. 1999. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J. Lipid Res. 40:1-16
113. 111. Makar RSJ, Lipsky PE, Cuthbert JA. 1998. Sterol-independent, streol response element-dependent, regulation of low density lipoprotein receptor gene expression. J. Lipid Res. 39:1647-54
114. r-40000 receptor-associated protein. Eur. J. Biochem. 248:583-91
115. 113. Masuzaki H, Jingami H, Matsuoka N, Nakagawa O, Ogawa Y, et al. 1996. Regulation of very-low-density lipoprotein receptor in hypertrophic rat heart. Circ. Res. 78:8-14
116. 114. Masuzaki H, Jingami H, Yamamoto T, Nakao K. 1994. Effects of estradiol on very low density lipoprotein receptor mRNA levels in rabbit heart. FEBS Lett. 347:211-14
117. 115. Medh JD, Bowen SL, Fry GL, Ruben S, Andracki M, et al. 1996. Lipoprotein lipase binds to low density lipoprotein receptors and induces receptor-mediated catabolism of very low density lipoproP teins in vitro. J. Biol. Chem. 271:17073-80
118. 116. Medh JD, Fry GL, Bowen SL, Pladet MW, Strickland DK, Chappell DA. 1995. The 39-kDa receptor-associated protein modulates lipoprotein catabolism by binding to LDL receptors. J. Biol. Chem. 270:536-40
119. 2-macroglobulin receptor and transport to endosomes. FEBS Lett. 360:70-74
120. 118. Mellman I. 1996. Endocytosis and molecular sorting. Annu. Rev. Cell Dev. Biol. 12:575-625
121. 119. Mikhailenko I, Kounnas MZ, Strickland DK. 1995. Low density lipoprotein receptor-related protein alpha 2-macroglobulin receptor mediates the cellular internalization and degradation of thrombospondin - a process facilitated by cell-surface proteoglycans. J. Biol. Chem. 270:9543-49
122. 120. Mikhailenko I, Krylov D, Argraves KM, Roberts DD, Liau G, Strickland DK. 1997. Cellular internalization and degradation of thrombospondin-1 is mediated by the amino-terminal heparin binding domain (HBD). High affinity interaction of dimeric HBD with the low density lipoprotein receptor-related protein. J. Biol. Chem. 272:6784-91
123. 2-macroglobulin receptor and epithelial glycoprotein-330: two giant receptors mediating endocytosis of multiple ligands. Biochim. Biophys. Acta 1197:197-213
124. 122. Moestrup SK, Cui SY, Vorum H, Bregengård C, Bjorn SE, et al. 1995. Evidence that epithelial glycoprotein 330/ megalin mediates uptake of polybasic drugs. J. Clin. Invest. 96:1404-13
125. 2-macroglobulin-proteinase complex is achieved by binding to adjacent receptors. J. Biol. Chem. 266:14011-17
126. 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res. 269:375-82
127. 2-macroglobulin receptor containing a cluster of eight complement-type repeats. J. Biol. Chem. 268:13691-96
128. 126. Moestrup SK, Kozyraki R, Kristiansen M, Kaysen JH, Rasmussen HH, et al. 1998. The intrinsic factor-vitamin B12 receptor and target of teratogenic antibodies is a megalin-binding peripheral membrane protein with homology to developmental proteins. J. Biol. Chem. 273:5235-42
129. 127. Moestrup SK, Nielsen S, Andreasen P, Jorgensen KE, Nykjaer A, et al. 1993. Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes. J. Biol. Chem. 268:16564-70
130. 128. Moir RD, Lynch T, Bush AI, Whyte S, Henry A, et al. 1998. Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain. J. Biol. Chem. 273:5013-19
131. 129. Mokuno H, Brady S, Kotite L, Herz J, Havel RJ. 1994. Effect of the 39-kDa receptor-associated protein on the hepatic uptake and endocytosis of chylomicron remnants and low density lipoproteins in the rat. J. Biol. Chem. 269:13238-43
132. 130. Morwald S, Yamazaki H, Bujo H, Kusunoki J, Kanaki T, et al. 1997. A novel mosaic protein containing LDL receptor elements is highly conserved in humans and chickens. Arterioscler. Thromb. Vasc. Biol. 17:996-1002
133. 131. Mukherjee S, Ghosh RN, Maxfield FR. 1997. Endocytosis. Physiol. Rev. 77: 759-803
134. 2-Macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J. Neurochem. 69:1904-11
135. 133. Nielsen KL, Holtet TL, Etzerodt M, Moestrup SK, Gliemann J, et al. 1996. Identification of residues in alpha-macroglobulins important for binding to the alpha(2)-macroglobulin receptor low density lipoprotein receptor-related protein. J. Biol. Chem. 271:12909-12
136. 134. Nielsen MS, Brejning J, Garcia R, Zhang H, Hayden MR, et al. 1997. Segments in the C-terminal folding domain of lipoprotein lipase important for binding to the low density lipoprotein receptor-related protein and to heparan sulfate proteoglycans. J. Biol. Chem. 272:5821-27
137. 135. Nielsen PR, Ellgaard L, Etzerodt M, Thogersen HC, Poulsen FM. 1997. The solution structure of the N-terminal domain of alpha2-macroglobulin receptor-associated protein. Proc. Natl. Acad. Sci. USA 94:7521-25
138. 136. Niemeier A, Gåfvels ME, Heeren J, Meyer N, Angelin B, Beisiegel U. 1996. VLDL receptor mediates the uptake of human chylomicron remnants in vitro. J. Lipid Res. 37:1733-42
139. 137. Novak S, Hiesberger T, Schneider WJ, Nimpf J. 1996. A new low density lipoprotein receptor homologue with 8 ligand binding repeats in brain of chicken and mouse. J. Biol. Chem. 271:11732-36
140. 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds lipoprotein lipase and β-migrating very low density lipoprotein associated with the lipase. J. Biol. Chem. 268:15048-55
141. 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. J. Biol. Chem. 269: 25668-76
142. 140. Nykjaer A, Nielsen M, Lookene A, Meyer N, Roigaard H, et al. 1994. A carboxyl-terminal fragment of lipoprotein lipase binds to the low density lipoprotein receptor-related protein and inhibits lipase-mcdiated uptake of lipoprotein in cells. J. Biol. Chem. 269: 31747-55
143. 2-macroglobulin receptor/LDL receptor-related protein binds urokinase plasminogen activator inhibitor type-1 complex. J. Biol. Chem. 267:14543-46
144. 2-macroglobulin signaling receptor. Biochemistry 36:12395-99
145. 143. Orlando RA, Exner M, Czekay RP, Yamazaki H, Saito A, et al. 1997. Identification of the second cluster of ligand-binding repeats in megalin as a site for receptor-ligand interactions. Proc. Natl. Acad. Sci. USA 94:2368-73
146. 144. Orlando RA, Farquhar MG. 1994. Functional domains of the receptor-associated protein (RAP). Proc. Natl. Acad. Sci. USA 91:3161-65
147. 145. Orlando RA, Kerjaschki D, Kurihara H, Biemesderfer D, Farquhar MG. 1992. gp330 associates with a 44-kDa protein in the rat kidney to form the Heymann nephritis antigenic complex. Proc. Natl. Acad. Sci. USA 89:6698-702
148. 2-macroglobulin receptor. Proc. Natl. Acad. Sci. USA 89:7422-26
149. 147. Orth K, Willnow TE, Herz J, Gething MJ, Sambrook J. 1994. Low density lipoprotein receptor-related protein is necessary for the internalization of both tissue-type plasminogen activator-inhibitor complexes and free tissue-type plasminogen activator. J. Biol. Chem. 269:21117-22
150. 148. Pak YK, Kanuck MP, Berrios D, Briggs MR, Cooper AD, Ellsworth JL. 1996. Activation of LDL receptor gene expression in HepG2 cells by hepatocyte growth factor. J. Lipid Res. 37:985-98
151. 149. Pannekoek H, Veerman H, Lambers H, Diergaarde P, Verweij CL, et al. 1986. Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family. EMBO J. 5:2539-44
152. 150. Poller W, Willnow TE, Hilpert J, Herz J. 1995. Differential recognition of alpha(1)-antitrypsin-elastase and alpha(1)-antichymotrypsin-cathepsin G complexes by the low density lipoprotein receptor-related protein. J. Biol. Chem. 270:2841-45
153. 151. Price DL, Sisodia SS, Borchelt DR. 1998. Alzheimer disease - when and why? Nat. Genet. 19:314-16
154. 152. Rijken DC. 1995. Plasminogen activators and plasminogen activator inhibitors: biochemical aspects. Baillieres Clin. Haematol. 8:291-312
155. 153. Rodenburg KW, Kjoller L, Petersen HH, Andreasen PA. 1998. Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor. Biochem. J. 329:55-63
156. 154. Rothman JE, Wieland FT. 1996. Protein sorting by transport vesicles. Science 272:227-34
157. 155. Rudling M, Olivecrona H, Eggertsen G, Angelin B. 1996. Regulation of rat hepatic low density lipoprotein receptors. In vivo stimulation by growth hormone is not mediated by insulin-like growth factor I. J. Clin. Invest. 97:292-99
158. 156. Russell DW, Brown MS, Goldstein JL. 1989. Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins. J. Biol. Chem. 264:21682-88
159. 157. Saito A, Pietromonaco S, Loo AKC, Farquhar MG. 1994. Complete cloning and sequencing of rat gp330/"megalin," a distinctive member of the low density lipoprotein receptor gene family Proc. Natl. Acad. Sci. USA 91:9725-29
160. 158. Sakai J, Hoshino A, Takahashi S, Miura Y, Ishii H, et al. 1994. Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene. J. Biol. Chem. 269:2173-82
161. 159. Schmid SL. 1997. Clathrin-coated vesicle formation and protein sorting: an integrated process. Annu. Rev. Biochem. 66:511-48
162. 160. Schneider WJ, Nimpf J, Bujo H. 1997. Novel members of the low density lipoprotein receptor superfamily and their potential roles in lipid metabolism. Curr. Opin. Lipidol. 8:315-19
163. 161. Shakibaei M, Frevert U. 1996. Dual interaction of the malaria circumsporozoite protein with the low density lipoprotein receptor-related protein (LRP) and heparan sulfate proteoglycans. J. Exp. Med. 184:1699-711
164. 162. Simonsen ACW, Heegaard CW, Rasmussen LK, Ellgaard L, Kjoller L, et al. 1994. Very low density lipoprotein receptor from mammary gland and mammary epithelial cell lines binds and mediates endocytosis of M(r) 40,000 receptor associated protein. FEBS Lett. 354:279-83
165. 163. Smythe E. 1996. Endocytosis. Sub-Cell. Biochem. 27:51-92
166. 164. Sottrup-Jensen L. 1989. α-Macroglobulins: structure, shape, and mechanism of proteinase complex formation. J. Biol. Chem. 264:11539-42
167. 165. Sprang SR. 1992. The latent tendencies of PAI-1. Trends Biochem. Sci. 17:49-50
168. 166. St. Clair RW, Beisiegel U. 1997. What do all the apolipoprotein E receptors do. Curr. Opin. Lipidol. 8:243-45
169. 167. Stefansson S, Chappell DA, Argraves KM, Strickland DK, Argraves WS. 1995. Glycoprotein 330/low density lipoprotein receptor-related protein-2 mediates endocytosis of low density lipoproteins via interaction with apolipoprotein B100. J. Biol. Chem. 270: 19417-21
170. 168. Stefansson S, Kounnas MZ, Henkin J, Mallampalli RK, Chappell DA, et al. 1995. gp330 on type II pneumocytes mediates endocytosis leading to degradation of pro-urokinase, plasminogen activator inhibitor-1 and urokinase-plasminogen activator inhibitor-1 complex. J. Cell Sci. 108:2361-68
171. 169. Stefansson S, Lawrence DA, Argraves WS. 1996. Plasminogen activator inhibitor-1 and vitronectin promote the cellular clearance of thrombin by low density lipoprotein receptor-related proteins 1 and 2. J. Biol. Chem. 271:8215-20
172. 170. Stefansson S, Muhammad S, Cheng XF, Battey FD, Strickland DK, Lawrence DA. 1998. Plasminogen activator inhibitor-1 contains a cryptic high affinity binding site for the low density lipoprotein receptor-related protein. J. Biol. Chem. 273:6358-66
173. 171. Storm D, Herz J, Trinder P, Loos M. 1997. C1 inhibitor-C1s complexes are internalized and degraded by the low density lipoprotein receptor-related protein. J. Biol. Chem. 272:31043-50
174. 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this protein is a multi-functional receptor. J. Biol. Chem. 265: 17401-4
175. 173. Strickland DK, Kounnas MZ, Argraves WS. 1995. LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J. 9:890-98
176. 174. Strickland DK, Kounnas MZ, Williams SE, Argraves WS. 1994. LDL receptor-related protein (LRP): a multifunctional receptor. Fibrinolysis 8(Suppl. 1):204-15
177. 175. Takahashi S, Kawarabayasi Y, Nakai T, Sakai J, Yamamoto T. 1992. Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc. Natl. Acad. Sci. USA 89:9252-56
178. 176. Takahashi S, Suzuki J, Kohno M, Oida K, Tamai T, et al. 1995. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. J. Biol. Chem. 270:15747-54
179. 177. Tanzi RE, Gusella JF, Watkins PC, Bruns GA, St George-Hyslop P, et al. 1987. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235: 880-84
180. 178. Van Dijk KW, van Vlijmen BJ, van der Zee A, van't Hof B, van der Boom H, et al. 1998. Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirus-mediated gene transfer of the VLDL receptor. Arterioscler. Thromb. Vasc. Biol. 18:7-12
181. 179. van Tilbeurgh H, Roussel A, Lalouel JM, Cambillau C. 1994. Lipoprotein lipase. Molecular model based on the pancreatic lipase X-ray structure: consequences for heparin binding and catalysis. J. Biol. Chem. 269:4626-33
182. 180. Vassalli J-D, Sappino A-P, Belin D. 1991. The plasminogen activator/plasmin system. J. Clin. Invest. 88:1067-72
183. 181. Vaziri ND, Liang K. 1997. Down-regulation of VLDL receptor expression in chronic experimental renal failure. Kidney Int. 51:913-19
184. 182. Warshawsky I, Broze GJ Jr, Schwartz AL. 1994. The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor. Proc. Natl. Acad. Sci. USA 91:6664-68
185. 183. Warshawsky I, Bu G, Schwartz AL. 1993. Identification of domains on the 39-kDa protein that inhibit the binding of ligands to the low density lipoprotein receptor-related protein. J. Biol. Chem. 268:22046-54
186. 184. Warshawsky I, Bu G, Schwartz AL. 1994. Binding analysis of amino-terminal and carboxyl-terminal regions of the 39-kDa protein to the low density lipoprotein receptor-related protein. J. Biol. Chem. 269:3325-30
187. 185. Warshawsky I, Bu G, Schwartz AL. 1995. Sites within the 39-kDa protein important for regulating ligand binding to the low-density lipoprotein receptor-related protein. Biochemistry 34:3404-15
188. 186. Watanabe Y, Inaba T, Shimano H, Gotoda T, Yamamoto K, et al. 1994. Induction of LDL receptor-related protein during the differentiation of monocyte-macrophages; possible involvement in the atherosclerotic process. Arterioscler. Thromb. 14:1000-6
189. 187. Wavrant-DeVrieze F, Perez-Tur J, Lambert JC, Frigard B, Pasquier F, et al. 1997. Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease. Neurosci. Lett. 227:68-70
190. 188. Webb JC, Patel DD, Jones MD, Knight BL, Soutar AK. 1994. Characterization and tissue-specific expression of the human 'very low density lipoprotein (VLDL) receptor' mRNA. Hum. Mol. Genet. 3:531-37
191. 189. Weisgraber KH, Mahley RW. 1996. Human apolipoprotein E: the Alzheimer's disease connection. FASEB J. 10:1485-94
192. 190. Williams SE, Inoue I, Tran H, Fry GL, Pladet MW, et al. 1994. The carboxyl-terminal domain of lipoprotein lipase binds to the low density lipoprotein receptor-related protein/alpha(2)-macroglobulin receptor (Lrp) and mediates binding of normal very low density lipoproteins to Lrp. J. Biol. Chem. 269:8653-58
193. 191. Willnow TE, Goldstein JL, Orth K, Brown MS, Herz J. 1992. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J. Biol. Chem. 267:26172-80
194. 192. Willnow TE, Hilpert J, Armstrong SA, Rohlmann A, Hammer RE, et al. 1996. Defective forebrain development in mice lacking gp330/megalin. Proc. Natl. Acad. Sci. USA 93:8460-64
195. 193. Willnow TE, Moehring JM, Inocencio NM, Moehring TJ, Herz J. 1996. The low-density-lipoprotein receptor-related protein (LRP) is processed by furin in vivo and in vitro. Biochem. J. 313:71-76
196. 194. Willnow TE, Orth K, Herz J. 1994. Molecular dissection of ligand binding sites on the low density lipoprotein receptor-related protein. J. Biol. Chem. 269:15827-32
197. 195. Willnow TE, Rohlmann A, Horton J, Otani H, Braun JR, et al. 1996. RAP, a specialized chaperone, prevents ligand-induced ER retention and degradation of LDL receptor-related endocytic receptors. EMBO J. 15:2632-39
198. 196. Willnow TE, Sheng ZQ, Ishibashi S, Herz J. 1994. Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. Science 264:1471-74
199. 197. Wilson C, Wardell MR, Weisgraber KH, Mahley RW, Agard DA. 1991. Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science 252:1817-22
200. 198. Wittmaack FM, Gåfvels ME, Bronner M, Matsuo H, McCrae KR, et al. 1995. Localization and regulation of the human very low density lipoprotein/ apolipoprotein-E receptor: Trophoblast expression predicts a role for the receptor in placental lipid transport. Endocrinology 136:340-48
201. 199. Wlodawer A, Nachman J, Gilliland GL, Gallagher W, Woodward C. 1987. Structure of form III crystals of bovine pancreatic trypsin inhibitor. J. Mol. Biol. 198: 469-80
202. 200. Wlodawer A, Walter J, Huber R, Sjolin L. 1984. Structure of bovine pancreatic trypsin inhibitor. Results of joint neutron and X-ray refinement of crystal form II. J. Mol. Biol. 180:301-29
203. 2-macroglobulin receptor in human malignant astrocytomas. Cancer Res. 57:2799-805
204. 202. Yamamoto T, Bujo H. 1996. Close encounters with apolipoprotein E receptors. Curr. Opin. Lipidol. 7:298-302
205. 203. Yamamoto T, Takahashi S, Sakai J, Kawarabayasi Y. 1993. The very low density lipoprotein receptor: a second lipoprotein receptor that may mediate uptake of fatty acids into muscle and fat cells. Trends Cardiovasc. Med. 3:144-48
206. 204. Yamazaki H, Bujo H, Kusunoki J, Seimiya K, Kanaki T, et al. 1996. Elements of neural adhesion molecules and a yeast vacuolar protein sorting receptor are present in a novel mammalian low density lipoprotein receptor family member. J. Biol. Chem. 271:24761-68
207. 205. Zheng G, Bachinsky DR, Stamenkovic I, Strickland DK, Brown D, et al. 1994. Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/ alpha 2MR, the receptor-associated protein (RAP). J. Histochem. Cytochem. 42: 531-42
208. 206. Zheng G, Marino M, Zhao J, McCluskey RT. 1998. Megalin (gp330): a putative endocytic receptor for thyroglobulin (Tg). Endocrinology 139:1462-65